Routine versus As-Needed Bevacizumab with 12-Weekly Assessment Intervals for Neovascular Age-Related Macular Degeneration: 92-Week Results of the GMAN Trial
| Autor: | Mahmood, Sajjad, Roberts, Stephen A., Aslam, Tariq M., Parkes, Jeremy, Barugh, Kate, Bishop, Paul N. |
|---|---|
| Zdroj: | In Ophthalmology July 2015 122(7):1348-1355 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|